Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma

Background: Progress in the diagnosis and treatment of clear cell renal cell carcinoma (ccRCC) has significantly prolonged patient survival. However, ccRCC displays an extreme heterogenous characteristic and metastatic tendency, which limit the benefit of targeted or immune therapy. Thus, identifyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Aimin, Ye, Juelan, Zhou, Ye, Zhu, Baohua, Lu, Juan, Ge, Silun, Qu, Le, Xiao, Jianru, Wang, Linhui, Cai, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913648/
https://www.ncbi.nlm.nih.gov/pubmed/36766692
http://dx.doi.org/10.3390/cells12030349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913648/
https://www.ncbi.nlm.nih.gov/pubmed/36766692
http://dx.doi.org/10.3390/cells12030349

Ejemplares similares